Abstract
The microheterogeneity of human transthyretin (TTR) is mainly one of ligand and amino acid substitutions. These substitutions modify the conformational stability of monomers, dimers, and tetramers and may eventually result in unfolding–refolding transitions with the endpoint of amyloidosis. In this chapter we focus on a structural peculiarity of human TTR, i.e., a hydrogen bridge between His31 (β-strand B) and Ser46 (β-strand C), which appears to be the vulnerable site for changes of pH within a range (pH 7.4–6.5) observed under conditions of interstitial acidosis. We present arguments in favor of a cooperative interaction of all sites in the TTR monomer in modifying its conformational stability and reversible unfolding-refolding transitions which also affect the dimer and tetramer. We postulate that the unfolded monomer is the pool from which amyloidogenic aggregates are generated.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsAbbreviations
- ATTR:
-
Amyloidogenic transthyretin
- CA:
-
Carrier ampholytes
- DTT:
-
Dithiothreitol
- FAP:
-
Familial amyloidotic polyneuropathy
- HEPES:
-
2-(4-(2-Hydroxyethyl)-1-piperazinyl)-ethanesulfonic acid
- IEF:
-
Isoelectric focusing
- MOPS:
-
3-(N-Morpholino)-propanesulfonic acid
- PAGE:
-
Polyacrylamide gel electrophoresis
- PIPES:
-
1,4-Piperazinediethane sulfonic acid
- RBP:
-
Retinol-binding protein
- SDS:
-
Sodium dodecylsulfate
- TTR:
-
Transthyretin
References
Agulló L, Garcia-Dorado D, Escalona N, Inserte J, Ruiz-Meana M, Barrabeé JA, Mirabet M, Pina P, Soler-Soler J (2002) Hypoxia and acidosis impair cGMP synthesis in microvascular coronary endothelial cells. Am J Physiol Heart Circ Physiol 383:H917–H925
Altland K, Benson MD, Costello CE, Ferlini A, Hazenberg BPC, Hund E, Kristen AV, Linke RP, Merlini G, Salvi F, Saraiva MJ, Singer R, Skinner M, Winter P (2007) Genetic microheterogeneity of human transthyretin detected by IEF. Electrophoresis 28:2053–2064
Altland K, Kast C, Rauh S, Sgraja T (1982) Demonstration of prealbumin, apolipoprotein AI and 7S-beta1-globulin from human blood by double one-dimensional electrophoresis. In: Peeters H (ed) Protides of the biological fluids. Vol 30. Pergamon Press, Oxford, pp 595–598
Altland K, Winter P (1999) Potential treatment of transthyretin-type amyloidosis by sulfite. Neurogenetics 2:183–188
Altland K, Winter P, Saraiva MJM, Suhr O (2004) Sulfite and base for the treatment of familial amyloidotic polyneuropathy: two additive approaches to stabilize the conformation of human amyloidogenic transthyretin. Neurogenetics 5:61–67
Altland K, Winter P, Sauerborn MK (1999) Electrically neutral microheterogeneity of human plasma transthyretin (prealbumin) detected by isoelectric focusing in urea gradients. Electrophoresis 20:1349–1364
Alves IL, Altland K, Almeida MR, Winter P, Saraiva MJ (1997) Screening and biochemical characterization of transthyretin variants in the Portuguese population. Human Mutat 9: 226–233
Benson MD (2003) The hereditary amyloidoses. Best Practice Res Clin Rheumatol 17:909–927
Blake CCF, Deisow MJ, Oatley SJ, Rérat B, Rérat C (1978) Structure of prealbumin: secondary, tertiary and quarternary interactions determined by Fourier Refinement at 1.8 Ǻ. J Mol Biol 121:339–356
Blake C, Serpell L (1996) Synchroton X-ray studies suggest that the core of the transthyretin amyloid fibril is a continuous beta-sheet helix. Structure 4:989–998
Brack CM, Duan W, Hulbert AJ, Schreiber G (1995) Wallaby transthyretin. Comp Biochem Physiol 110B:523–529
Colon W, Kelly JW (1992) Partial denaturation of transthyretin is sufficient for amyloid fibril formation in vitro. Biochemistry 31:8654–8660
Connors LH, Lim A, Amareth L, Prokaeva T, Roskens VA, Costello CE (2003) Tabulation of human transthyretin (TTR) variants, 2003. Amyloid: J Protein Folding Disord 10:160–184
Cornwell GG, Murdoch WL, Kyle RA, Wetsermark P, Pitkänen P (1983) Frequency and distribution of senile cadiovascular Amyloid. Am J Med 75:618–623
Ehrnhoefer DE, Bieschke J, Boeddrich A, Herbst M, Masino L, Kurz R, Engemann S, Pastore A, Wanker EE (2008) EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers. Nature Struct Mol Biol 15:558–566
Feldin P, Fex G (1984) The increased negative charge of prealbumin in cerebrospinal fluid is acquired in vitro by oxidation of the cysteinylated residue without formation of disulfides. Scand J Clin Lab Invest 44:231–238
Fitch NJS, Akbari MT, Ramsden DB (1991) An inherited non-amyloidogenic transthyretin variant, [Ser6]-TTR, with increased thyroxine-binding affinity, characterized by DNA sequencing. J Endocrinol 129:309–313
Gales L, Saraiva MJ, Damas AM (2007) Structural basis for the protective role of sulfite against transthyretin amyloid formation. Biochim Biophys Acta 1774:59–64
Hack V, Breitkreuz R, Kinscherf R, Röhrer H, Bärtsch P, Taut F, Benner A, Dröge W (1998) The redox state as a correlate of senescence and wasting and as a target for therapeutic intervention. Blood 92:59–67
Helmlinger G, Yuan F, Dellian M, Jain RK (1997) Interstitial pH and pO2 gradients in solid tumors in vivo: high resolution measurements reveal a lack of correlation. Nat Med 3: 177–182
Hörnberg A, Eneqvist T, Olofsson A, Lundgren E, Sauer-Eriksson AE (2000) A comparative analysis of 23 structures of the amyloidogenic protein transthyretin. J Mol Biol 22:649–669
Holmgren G, Ando Y, Wikström L, Rygh A, Suhr O (1997) Discordant symptoms in monozygotic twins with familial amyloidotic polyneuropathy (FAP) (TTR met30). Amyloid: J Protein Folding Disord 4:178–180
Hunstein W (2007) Epigallocathechin-3-gallate in AL amyloidosis: a new therapeutic option? Blood 110:2216 (letter)
Jacobson DR, McFarlin DE, Kane I, Buxbaum JN (1992) Transthyretin Pro55, a variant associated with early-onset, aggressive, diffuse amyloidosis with cardiac and neurological involvement. Hum Genet 89:353–356
Jenne DE, Denzel K, Blätzinger P, Winter P, Obermaier B, Linke RP, Altland K (1996) A new isoleucine substitution of Val-20 in transthyretin tetramers selectively impairs dime-dimer contacts and causes systemic amyloidosis. Proc Natl Acad Sci USA 93:6302–6307
Jones DP (2006) Extracellular redox state: refining the definition of oxidative stress in aging. Rejuvenation Res 9:169–181
Kanda Y, Goodman DS, Canfield RE, Morgan FJ (1974) The amino acid sequence of human plasma prealbumin. J Biol Chem 249:6796–6805
Kishikawa M, Nakanishi T, Miyasaki A, Shimizu A (1999) A simple and reliable method of detecting variant transthyretins by mutidimensional liquid chromatography coupled with electrospray ionization mass spectrometry. Amyloid: J Protein Folding Disord 6:48–53
Kubasiak LA, Hernandez OM, Bishopric NH, Webster KA (2002) Hypoxia and acidosis activate cardiac myocyte death through the Bcl-2 family protein BNIP3. Proc Natl Acad Sci USA 99:12825–12830
Kyle RA, Gertz MA, Linke RP (1992) Amyloid localized to tenosynovium at carpal tunnel release. Immunohistochemical identification of amyloid type. Am J Clin Pathol 97:250–253
Kyle RA, Spittell PC, Gertz MA, Li CY, Edwards WD, Olson LJ, Thibodeau SN (1996) The premortem recognition of systemic senile amyloidosis with cardiac involvement. Am J Med 101:395–400
Lashuel HA, Lai Z, Kelly JW (1998) Characterization of the transthyretin acid denaturation pathways by analytical ultracentrifugation: implication for wild-type, V30M, and L55P amyloid fibril formation. Biochemistry 37:17851–17864
Mansoor MA, Svardal AM, Ueland PM (1992) Determination of the in vivo redox status of cysteine, cysteinylglycine, and glutathione in human plasma. Anal Biochem 200:218–229
Marzouk SAM, Buck RP, Dunlap LA, Johnson TA, Cascio WE (2002) Measurement of extracellular pH, K +, and lactate in ischemic heart. Anal Biochem 308:52–60
Mills BJ, Weiss MM, Lang CA, Liu MC, Ziegler C (2000) Blood glutathion and cysteine changes in cardiovascular disease. J Lab Clin Med 135:396–401
Monaco HL, Rizzi M, Coda A (1995) Structure of a complex of two plasma proteins: transthyretin and retinol-binding protein. Science 268:1039–1041
Moriarty-Craige SE, Adkinson J, Lynn M, Gensler G, Bressler S, Jones DP, Sternberg P (2005) Antioxidant supplements prevent oxidation of cysteine/cystine redox in patients with age-related macular degeneration. Am J Ophthalmol 140:1020–1026
Nepomuceno AI, Mason CJ, Muddiman DC, Bergen III HR, Zeldenrust SR (2004) Detection of genetic variants of transthyretin by liquid chromatography-dual electrospray ionization Fourier-transform ion-cyclotron-resonance mass spectrometry. Clin Chem 50:1535–1543
Nolin TD, McMenamin ME, Himmelfarb J (2007) Simultaneous determination of total homocysteine, cysteine, cysteinylglycine, and glutathione in human plasma by high-performance liquid chromatography: application to studies of oxidative stress. J Chromatogr B 852:554–561
Ono K, Hasegawa K, Naiki H, Yamada M (2004) Curcumin has potential anti-amyloidogenic effects for Alzheimer's β-amyloid fibrils in vitro. J Neurosci Res 75:742–750
Planté-Bordeneuve V, Carayol J, Ferreira A, Adams D, Clerget-Darpoux F, Misrahi M, Said G, Bonaïti-Pellié C (2003) Genetic study of transthyretin amyloid neuropathies: carrier risk among French and Portuguese families. J Med Genet 40(11):e120
Richardson SJ (2007) Cell and molecular biology of transthyretin and thyroid hormones. Int Rev Cytol 258:137–193
Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas PSSR (1998) Influence of Piperine on the pharmacokinetics of Curcumin in animals and human volunteers. Planta Medica 64: 353–356
Street D, Bangsbo J, Juel C (2001) Interstitial pH in human muscle during and after dynamic graded exercise. J Physiol 537:993–998
Tannock IF, Rotin D (1989) Acid pH in tumors and its potential for therapeutic exploitation. Cancer Res 49:4373–4384
Théberge R, Connors L, Skinner M, Skare J, Costello CE (1999) Characterization of transthyretin mutants from serum using immunoprecipitation, HPLC/ electrospray ionization and matrix-assisted laser desorption/ionization mass spectrometry. Anal Chem 71:452–459
Trevani AS, Andonegui G, Giordano M, López DH, Gamberale R, Minucci F, Geffner JR (1999) Extracellular acidifcation induces human neutrophil activation. J Immunol 162:4849–4857
Westermark P, Berström J, Solomon A, Murphy C, Sletten K (2003) Thransthyretin-derived senile systemic amyloidosis: clinicopathological and structural considerations. Amyloid: J Protein Folding Disord 10 (Suppl 1):48–54
Westermark P, Sletten K, Johansson B, Cornwell GG (1990) Fibril in senile systemic amyloidosis is derived from normal transthyretin. Proc Natl Acad Sci USA 87:2843–2845
Yang F, Lim GP, Begum AN, Ubeda OJ, Simmons MR, Ambegaokar SS, Chen P, Kayed R, Glabe CG, Frautschy SA, Cole GM (2005) Curcumin inhibits formation of amyloid β oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem 280:5892–5901
Zhang O, Kelly JW (2003) Cys-10 mixed disulfides make transthyretin more amyloidogenic under mildly acidic conditions. Biochemistry 42:8756–8761
Acknowledgment
We appreciate the technical assistance of Pia Winter.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Altland, K., Richardson, S.J. (2009). Histidine 31: The Achilles' Heel of Human Transthyretin. Microheterogeneity is Not Enough to Understand the Molecular Causes of Amyloidogenicity. In: Richardson, S.J., Cody, V. (eds) Recent Advances in Transthyretin Evolution, Structure and Biological Functions. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-00646-3_13
Download citation
DOI: https://doi.org/10.1007/978-3-642-00646-3_13
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-00645-6
Online ISBN: 978-3-642-00646-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)